Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

An updated meta-analysis of XRCC4 polymorphisms and cancer risk based on 31 case-control studies.

Shao N, Jiang WY, Qiao D, Zhang SG, Wu Y, Zhang XX, Hua LX, Ding Y, Feng NH.

Cancer Biomark. 2012-2013;12(1):37-47. doi: 10.3233/CBM-120292.

PMID:
23321468
2.

Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.

Chang CH, Chang CL, Tsai CW, Wu HC, Chiu CF, Wang RF, Liu CS, Lin CC, Bau DT.

Anticancer Res. 2009 May;29(5):1777-82.

3.

A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients.

Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang CH, Wu CN, Lin CC, Bau DT.

Oral Oncol. 2008 Sep;44(9):898-902. doi: 10.1016/j.oraloncology.2007.11.007. Epub 2008 Mar 4.

PMID:
18164646
4.

Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.

Tseng RC, Hsieh FJ, Shih CM, Hsu HS, Chen CY, Wang YC.

Cancer. 2009 Jul 1;115(13):2939-48. doi: 10.1002/cncr.24327.

5.

A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan.

Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR, Bau DT.

Ann Surg Oncol. 2008 Feb;15(2):514-8. Epub 2007 Nov 7.

PMID:
17987338
6.

Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan.

Hsu NY, Wang HC, Wang CH, Chang CL, Chiu CF, Lee HZ, Tsai CW, Bau DT.

Cancer Biomark. 2009;5(4):159-65. doi: 10.3233/CBM-2009-0617.

PMID:
19729825
7.

Lack of association between Bax promoter (-248G>A) single nucleotide polymorphism and susceptibility towards cancer: evidence from a meta-analysis.

Sahu SK, Choudhuri T.

PLoS One. 2013 Oct 17;8(10):e77534. doi: 10.1371/journal.pone.0077534. eCollection 2013.

8.

Association of functional polymorphisms of the XRCC4 gene with the risk of breast cancer: a meta-analysis.

Zhou LP, Luan H, Dong XH, Jin GJ, Ma DL, Shang H.

Asian Pac J Cancer Prev. 2012;13(7):3431-6.

9.

[The study of esophageal cancer risk associated with polymorphisms of DNA damage repair genes XRCC4 and RAD51].

Fan XJ, Ren PL, Lu ZJ, Zhao S, Yang XL, Liu J.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Jul;44(4):568-72. Chinese.

PMID:
24059110
10.

Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis.

Zhang L, Wang J, Xu L, Zhou J, Guan X, Jiang F, Wu Y, Fan W.

Mutagenesis. 2012 Jan;27(1):67-76. doi: 10.1093/mutage/ger062. Epub 2011 Oct 13.

PMID:
22002622
11.

IL-10 polymorphisms and prostate cancer risk: a meta-analysis.

Shao N, Xu B, Mi YY, Hua LX.

Prostate Cancer Prostatic Dis. 2011 Jun;14(2):129-35. doi: 10.1038/pcan.2011.6. Epub 2011 Feb 22.

PMID:
21339768
12.

Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan.

Tseng HC, Tsai MH, Chiu CF, Wang CH, Chang NW, Huang CY, Tsai CW, Liang SY, Wang CL, Bau DT.

Anticancer Res. 2008 May-Jun;28(3A):1687-91.

13.

Significant association of XRCC4 single nucleotide polymorphisms with childhood leukemia in Taiwan.

Wu KH, Wang CH, Yang YL, Peng CT, Lin WD, Tsai FJ, Lin DT, Bau DT.

Anticancer Res. 2010 Feb;30(2):529-33.

PMID:
20332465
14.

Colorectal cancer and genetic polymorphism of DNA double-strand break repair gene XRCC4 in Taiwan.

Bau DT, Yang MD, Tsou YA, Lin SS, Wu CN, Hsieh HH, Wang RF, Tsai CW, Chang WS, Hsieh HM, Sun SS, Tsai RY.

Anticancer Res. 2010 Jul;30(7):2727-30.

PMID:
20683005
15.

An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs.

Yu H, Zhao H, Wang LE, Han Y, Chen WV, Amos CI, Rafnar T, Sulem P, Stefansson K, Landi MT, Caporaso N, Albanes D, Thun M, McKay JD, Brennan P, Wang Y, Houlston RS, Spitz MR, Wei Q.

DNA Repair (Amst). 2011 Apr 3;10(4):398-407. doi: 10.1016/j.dnarep.2011.01.005. Epub 2011 Feb 5.

16.

Significant association of XRCC4 single nucleotide polymorphisms with prostate cancer susceptibility in Taiwanese males.

Chang CH, Chiu CF, Wu HC, Tseng HC, Wang CH, Lin CC, Tsai CW, Liang SY, Wang CL, Bau DT.

Mol Med Rep. 2008 Jul-Aug;1(4):525-30.

PMID:
21479444
17.

The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.

Tang Z, Nie ZL, Pan Y, Zhang L, Gao L, Zhang Q, Qu L, He B, Song G, Zhang Y, Shukui Wang.

Mutagenesis. 2011 Nov;26(6):729-34. doi: 10.1093/mutage/ger040. Epub 2011 Jul 6.

PMID:
21734230
18.

Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan.

Yen CY, Liu SY, Chen CH, Tseng HF, Chuang LY, Yang CH, Lin YC, Wen CH, Chiang WF, Ho CH, Chen HC, Wang ST, Lin CW, Chang HW.

J Oral Pathol Med. 2008 May;37(5):271-7. doi: 10.1111/j.1600-0714.2007.00608.x.

PMID:
18410587
19.

The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.

Wang J, Ding Q, Shi Y, Cao Q, Qin C, Zhu J, Chen J, Yin C.

Mutagenesis. 2012 May;27(3):305-12. doi: 10.1093/mutage/ger078. Epub 2011 Nov 4.

PMID:
22058059
20.

A role for XRCC4 in age at diagnosis and breast cancer risk.

Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ.

Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1306-10.

Supplemental Content

Support Center